Efficacy of surfactant at different gestational ages for infants with respiratory distress syndrome

Li Wang, Long Chen, Renjun Li, Jinning Zhao, Xiushuang Wu, Xue Li, Yuan Shi, Li Wang, Long Chen, Renjun Li, Jinning Zhao, Xiushuang Wu, Xue Li, Yuan Shi

Abstract

Since exogenous surfactant replacement therapy was first used to prevent respiratory distress syndrome (RDS), it has become the main method for treatment of RDS. However, in some infants, death is inevitable despite intensive care and surfactant replacement therapy, especially in near-term and term infants. The main purpose of this study was to compare the therapeutic effect of pulmonary surfactant for infants at different gestational ages and to investigate whether exogenous surfactant replacement therapy is effective for all newborns with RDS. Data on surfactant replacement therapy, including blood gas, oxygenation function parameters and therapy results, were collected from 135 infants who were diagnosed with RDS during three years at a tertiary neonatal intensive care unit. According to gestational age, the subjects were classified into three groups as follows: group 1: gestational age <35 weeks (n=54); group 2: 35 weeks ≤ gestational age <37 weeks (n=35); group 3: gestational age ≥37 weeks (n=46). Six hours after surfactant was given, there were significantly better blood gas results in group 1 and worse results in groups 2 and 3. Similar oxygenation function parameter results were observed in the three groups. In addition, there was a trend toward an increased rate of repeated surfactant administration with increasing gestational age. For near-term and term infants, the efficacy of surfactant therapy was not as good as it was for preterm infants. The causes of RDS in near-term and term infants might be different from those in preterm infants and should be studied further.

Keywords: Surfactant; gestational age; infants; respiratory distress syndrome.

Figures

Figure 1
Figure 1
Flow diagram of the study selection process.

References

    1. Angus DC, Linde-Zwirble WT, Clermont G, Griffin MF, Clark RH. Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. Am J Respir Crit Care Med. 2001;164:1154–1160.
    1. Bhakoo ON, Narang A, Karthikeyan G, Kumar P. Spectrum of respiratory distress in very low birthweight neonates. Indian J Pediatr. 2000;67:803–804.
    1. Ma CC, Ma S. The role of surfactant in respiratory distress syndrome. Open Respir Med J. 2012;6:44–53.
    1. Sehgal A, Mak W, Dunn M, Kelly E, Whyte H, McCrindle B, McNamara PJ. Haemodynamic changes after delivery room surfactant administration to very low birth weight infants. Arch Dis Child Fetal Neonatal Ed. 2010;95:345–51.
    1. van Kaam AH, De Jaegere AP, Borensztajn D, Rimensberger PC Neovent Study Group. Surfactant replacement therapy in preterm infants: a European survey. Neonatology. 2011;100:71–77.
    1. Dani C. Surfactant replacement in preterm infants with respiratory distress syndrome. Acta Biomed. 2012;83:17–20.
    1. Speer CP, Sweet DG, Halliday HL. Surfactant therapy: past, present and future. Early Hum Dev. 2013;89:22–24.
    1. Moya F, Sinha S, D’Agostino RB Sr. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections. Pediatrics. 2008;121:1290–1291.
    1. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163:1376–1383.
    1. Gerten KA, Coonrod DV, Bay RC, Chambliss LR. Cesarean delivery and respiratory distress syndrome: does labor make a difference? Am J Obstet Gynecol. 2005;193:1061–1064.
    1. Hamvas A, Cole FS, Nogee LM. Genetic disorders of surfactant proteins. Neonatology. 2007;91:311–317.
    1. Kero PO, Mäkinen EO. Comparison between clinical and radiological classification of infants with the respiratory distress syndrome (RDS) Eur J Pediatr. 1979;130:271–278.
    1. Tsakalidis C, Giougki E, Karagianni P, Dokos C, Rallis D, Nikolaidis N. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants? Turk J Pediatr. 2012;54:368–375.
    1. Stoelhorst GM, Rijken M, Martens SE, Brand R, den Ouden AL, Wit JM, Veen S Leiden Follow-Up Project on Prematurity. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project On Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997. Pediatrics. 2005;115:396–405.
    1. Ventolini G, Neiger R, Mathews L, Adragna N, Belcastro M. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation. Am J Perinatol. 2008;25:79–83.
    1. Engle WA American Academy of Pediatrics Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics. 2008;121:419–432.
    1. Chen A, Shi LP, Zheng JY, Du LZ. Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates. Zhonghua Er Ke Za Zhi. 2008;46:654–657.
    1. Mathews TJ, MacDorman MF. Infant mortality statistics from the 2005 period linked birth/infant death data set. Natl Vital Stat Rep. 2008;57:1–32.
    1. Jain L, Eaton DC. Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol. 2006;30:34–43.
    1. Deng W, Klemetti R, Long Q, Wu Z, Duan C, Zhang WH, Ronsmans C, Zhang Y, Hemminki E. Cesarean section in Shanghai: women’s or Healthcare provider’s preferences? BMC Pregnancy Childbirth. 2014;14:285.
    1. Roth-Kleiner M, Wagner BP, Bachmann D, Pfenninger J. Respiratory distress syndrome in near-term babies after caesarean section. Swiss Med Wkly. 2003;133:283–288.
    1. Helve O, Pitkänen O, Janér C, Andersson S. Pulmonary fluid balance in the human newborn infant. Neonatology. 2009;95:347–352.
    1. Tsakalidis C, Giougki E, Karagianni P, Dokos C, Rallis D, Nikolaidis N. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants? Turk J Pediatr. 2012;54:368–375.
    1. Berthelot-Ricou A, Lacroze V, Courbiere B, Guidicelli B, Gamerre M, Simeoni U. Respiratory distress syndrome after elective caesarean section in near term infants: a 5-year cohort study. J Matern Fetal Neonatal Med. 2013;26:176–182.
    1. Sun H, Xu F, Xiong H, Kang W, Bai Q, Zhang Y, Zhou C, Zhuang F, Wang X, Zhu C. Characteristics of respiratory distress syndrome in infants of different gestational ages. Lung. 2013;191:425–433.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner